4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-032803
Chief Business Development Off sold 416 shares at $42.00 ($17,472)
- Chief Business Development Off acquired 416 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Business Development Off | 2020-05-26 | Option exercise | +416 | $6.32 | $2,629 | 416 | D |
| BENZENO SHARON Chief Business Development Off | 2020-05-26 | Sale | −416 | $42.00 | $17,472 | 0 | D |
| Derivatives | |||||||
| BENZENO SHARON Chief Business Development Off | 2020-05-26 | Option exercise · Stock Option (Right to Buy) | −416 | 834 | D | ||
| Open-market sales · 416 sh · avg $42.00 · $17,472 | |||||||
Loading xslF345X03/doc4.xml…